Secondaries announced 12.20.2016

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.

Company: RedHill Biopharma Ltd.
Symbol: RDHL
Price: Last trade $10.81
Description: No re-offer range available
Trade Date: 12/21
Shares: TBD
Underwriter(s)Roth Capital Partners
Rating=Subscription Needed